Cryosurgical ablation of the prostate.
Keetch DW, Moore S, Shea L.
AORN J. 1995 May;61(5):807-13; quiz 816-7, 819-20. doi: 10.1016/s0001-2092(06)63712-5.
Mechanisms of cryoablation: clinical consequences on malignant tumors.
Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM.
Cryobiology. 2014 Feb;68(1):1-11. doi: 10.1016/j.cryobiol.2013.11.001. Epub 2013 Nov 13.
Nano-cryosurgery: advances and challenges.
Liu J, Deng ZS.
J Nanosci Nanotechnol. 2009 Aug;9(8):4521-42. doi: 10.1166/jnn.2009.1264.
Issues critical to the successful application of cryosurgical ablation of the prostate.
Baust JG, Gage AA, Klossner D, Clarke D, Miller R, Cohen J, Katz A, Polascik T, Clarke H, Baust JM.
Technol Cancer Res Treat. 2007 Apr;6(2):97-109. doi: 10.1177/153303460700600206.
Cryotherapy.
Loening SA, Bonney WW, Fallon B, Gerber WL, Hawtrey CE, Lubaroff DM, Narayana AS, Culp DA.
Prostate. 1984;5(2):199-204. doi: 10.1002/pros.2990050209.
Cryosurgery of malignant and premalignant diseases of the skin: a simple approach.
Sinclair RD, Dawber RP.
Australas J Dermatol. 1995 Aug;36(3):133-42. doi: 10.1111/j.1440-0960.1995.tb00955.x.
Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1.
van der Geest IC, de Valk MH, de Rooy JW, Pruszczynski M, Veth RP, Schreuder HW.
J Surg Oncol. 2008 Nov 1;98(6):421-6. doi: 10.1002/jso.21122.
Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy.
Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP.
Surgery. 1997 Dec;122(6):1040-7; discussion 1047-8. doi: 10.1016/s0039-6060(97)90207-5.
Cryosurgical treatment of skin diseases.
Krahwinkel DJ Jr.
Vet Clin North Am Small Anim Pract. 1980 Nov;10(4):787-801. doi: 10.1016/s0195-5616(80)50080-x.
Progress toward optimization of cryosurgery.
Baust JG, Gage AA.
Technol Cancer Res Treat. 2004 Apr;3(2):95-101. doi: 10.1177/153303460400300202.
